Dna X Inc (SONM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,498 | -10,723 | -5,124 | 1,277 | -3,060 |
| Depreciation Amortization | 2,669 | 1,798 | 892 | 1,850 | 1,339 |
| Income taxes - deferred | -7 | -11 | -11 | 140 | -100 |
| Accounts receivable | 1,507 | -12,420 | 11,379 | -8,065 | -8,303 |
| Accounts payable and accrued liabilities | -9,710 | -9,928 | -298 | 16,049 | 13,236 |
| Other Working Capital | -21,859 | -31,294 | -91 | -1,127 | -1,881 |
| Other Operating Activity | 16,095 | 27,794 | -11,275 | -6,263 | -3,218 |
| Operating Cash Flow | $-28,803 | $-34,784 | $-4,528 | $3,861 | $-1,987 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,255 | -491 | -191 | -2,545 | -1,970 |
| Investing Cash Flow | $-1,255 | $-491 | $-191 | $-2,545 | $-1,970 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,614 | 5,614 | N/A | 77,127 | 67,809 |
| Debt Repayment | -9,235 | -5,878 | -123 | -75,265 | -63,884 |
| Common Stock Issued | 38,853 | 40,058 | 1,645 | 8,312 | 12 |
| Other Financing Activity | -1,874 | -1,874 | 0 | -22 | -30 |
| Financing Cash Flow | $33,358 | $37,920 | $1,522 | $10,152 | $3,907 |
| Beginning Cash Position | 13,049 | 13,049 | 13,049 | 1,581 | 1,581 |
| End Cash Position | 16,349 | 15,694 | 9,852 | 13,049 | 1,531 |
| Net Cash Flow | $3,300 | $2,645 | $-3,197 | $11,468 | $-50 |
| Free Cash Flow | |||||
| Operating Cash Flow | -28,803 | -34,784 | -4,528 | 3,861 | -1,987 |
| Capital Expenditure | -1,255 | -491 | -191 | -2,545 | -1,970 |
| Free Cash Flow | -30,058 | -35,275 | -4,719 | 1,316 | -3,957 |